Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis.
Sîrbulescu RF, Nicholson K, Kawai K, Hilton OM, Sobell D, Jin G, Verrill DE, Dwyer LJ, Xiong Y, Bachanová P, Kim SE, Gallup S, Gelevski D, Daley H, Hernandez Rodriguez DE, Negre H, Sturtevant O, Nikiforow S, Ritz J, Chen YB, Reeves PM, Sluder AE, Berry JD, Sadri-Vakili G, Cudkowicz M, Poznansky MC.
Sîrbulescu RF, et al. Among authors: kim se.
FASEB J. 2024 Jul 15;38(13):e23796. doi: 10.1096/fj.202302659R.
FASEB J. 2024.
PMID: 38967302